Medtech lobby seeks broader device eligibility for CMS' proposed RAPID pathway

AdvaMed is advocating for expanded eligibility under CMS's RAPID pathway to include more breakthrough devices such as diagnostics, and for established timelines for national coverage determinations. This regulatory development affects medical device manufacturers and HTM procurement decisions.